Full article: Low-dose aspirin for early COVID-19: does the early bird catch the worm?
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation | Nature Reviews Cardiology
Medicina | Free Full-Text | Aspirin Is Related to Worse Clinical Outcomes of COVID-19
Aspirin may reduce risk of severe COVID symptoms: Study
Aspirin & COVID-19 | The International Aspirin Foundation
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial - British Journal of Anaesthesia
Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico - International Journal of Infectious Diseases
Frontiers | Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
Frontiers | Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation
Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS) | Archivos de Bronconeumología
The effects of aspirin on the outcome of COVID-19: A systematic review and meta-analysis - Clinical Epidemiology and Global Health
COVID-19 therapeutics: Challenges and directions for the future | PNAS
Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis - eClinicalMedicine
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry | Journal of the American Heart Association
Aspirin | C9H8O4 | CID 2244 - PubChem
Neurology International | Free Full-Text | Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities
A guide to immunotherapy for COVID-19 | Nature Medicine
Medicina | Free Full-Text | Aspirin Is Related to Worse Clinical Outcomes of COVID-19
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? | Drugs
Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence- - International Journal of Cardiology
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection - The American Journal of Medicine
Biomedicines | Free Full-Text | Aspirin and Infection: A Narrative Review
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial - The Lancet Respiratory Medicine
Association of mortality and aspirin use for COVID-19 residents at VA Community Living Center Nursing Homes | medRxiv
